Key Development Global healthcare leader Johnson & Johnson (J&J) has officially finalized its acquisition of biotechnology innovator Firefly Bio Inc.... Read more
Tag: #M&A
Mega-Merger Dynamics: AstraZeneca Holds Preliminary $400 Billion Consolidation Talks With Bristol Myers Squibb (BMY) to Form World’s 4th Largest Pharma Giant
Key Development British pharmaceutical major AstraZeneca (AZN) and U.S. oncology leader Bristol Myers Squibb (BMY) are reported to be in... Read more
AMERICAN INDUSTRIAL PARTNERS COMPLETES AVANOS MEDICAL ACQUISITION AND EXPANDS ITS MEDTECH PRESENCE
Key Development American Industrial Partners has completed its acquisition of Avanos Medical in a transaction valued at approximately US$1.27 billion.... Read more
RIVERPOINT MEDICAL ACQUISITION MOVES NOVANTA DEEPER INTO THE SURGICAL CONSUMABLES MARKET
Key Development Novanta has completed its acquisition of Riverpoint Medical from Arlington Capital Partners, marking a significant expansion of its... Read more
ELI LILLY’S $3.8 BILLION ATAIBECKLEY ACQUISITION SIGNALS BIG PHARMA’S NEXT BET ON NEUROSCIENCE
Key Development Eli Lilly's agreement to acquire AtaiBeckley for up to US$3.8 billion represents more than another biotechnology acquisition it... Read more
IS MEDTECH BECOMING HEALTHCARE’S NEXT M&A HOTSPOT? CONMED WEIGHS STRATEGIC OPTIONS AMID TAKEOVER INTEREST
Takeover speculation lifts investor confidence Shares of medical technology company CONMED Corporation surged in after-hours trading after Bloomberg reported that... Read more
WHY WOULD INVESTORS PAY MORE THAN $7 BILLION FOR A SPECIALTY PHARMACY?
Private equity firm Warburg Pincus is reportedly nearing an agreement to acquire PANTHERx Rare in a transaction valued at more... Read more
WHY THE MERGER OF BAC TAN UYEN REGIONAL MEDICAL CENTER COULD SIGNAL A NEW DIRECTION FOR VIETNAM’S PUBLIC HEALTHCARE SYSTEM
Not every healthcare reform begins with the construction of a new hospital. Sometimes, it begins with a decision to reorganize... Read more
Post-Pandemic Restructuring: BioNTech Executes Confidential Divestment Talks Over 4 German Manufacturing Sites to Fund Oncology Pivot
Key Development German biotechnology pioneer BioNTech SE—the co-developer of the blockbuster Comirnaty mRNA COVID-19 vaccine—has initiated highly confidential discussions with... Read more









